Ligand Pharmaceuticals LGND Compensation and benefits
Compensation and benefits at other companies
Other financials
Where this comes from
Reported directly by Ligand Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ligand Pharmaceuticals's compensation and benefits.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Ligand Pharmaceuticals's compensation and benefits?
- Ligand Pharmaceuticals (LGND) reported compensation and benefits of $3.55M in Q1 2026.
- How has Ligand Pharmaceuticals's compensation and benefits changed year-over-year?
- Ligand Pharmaceuticals's compensation and benefits increased by 87.9% year-over-year, from $1.89M to $3.55M.
- What is the long-term trend for Ligand Pharmaceuticals's compensation and benefits?
- Over 5 years (2020 to 2025), Ligand Pharmaceuticals's compensation and benefits has grown at a -6.2% compound annual growth rate (CAGR), from $8.81M to $6.39M.